Predictions
Altran Technologies S.A.
Start price
Target price
Perf. (%)
€14.28
04.07.17
04.07.17
€16.00
18.07.17
18.07.17
6.79%
18.07.17
18.07.17
Herbalife Nutrition Ltd.
Start price
Target price
Perf. (%)
€32.12
04.07.17
04.07.17
€33.15
12.07.17
12.07.17
3.23%
12.07.17
12.07.17
Herbalife Nutrition Ltd.
Start price
Target price
Perf. (%)
€35.62
04.07.17
04.07.17
€36.75
12.07.17
12.07.17
3.23%
12.07.17
12.07.17
Xinjiang Goldwind Science & Technology Co Ltd
Start price
Target price
Perf. (%)
€1.04
04.07.17
04.07.17
€1.44
13.11.17
13.11.17
38.78%
13.11.17
13.11.17
Bank of Ireland Group
Start price
Target price
Perf. (%)
€6.99
03.07.17
03.07.17
€8.64
17.05.18
17.05.18
6.80%
17.05.18
17.05.18
GCL-Poly Energy Holdings Ltd
Start price
Target price
Perf. (%)
€0.85
01.07.17
01.07.17
€1.00
24.07.17
24.07.17
10.59%
24.07.17
24.07.17
GCL-Poly Energy Holdings Ltd
Start price
Target price
Perf. (%)
€0.10
01.07.17
01.07.17
€0.12
24.07.17
24.07.17
10.59%
24.07.17
24.07.17
HELLA GmbH & Co. KGaA
Start price
Target price
Perf. (%)
€43.95
01.07.17
01.07.17
€46.00
20.07.17
20.07.17
5.79%
20.07.17
20.07.17
HELLA GmbH & Co. KGaA
Start price
Target price
Perf. (%)
€43.95
01.07.17
01.07.17
€46.00
20.07.17
20.07.17
5.79%
20.07.17
20.07.17
Austria Microsystems AG
Start price
Target price
Perf. (%)
€55.99
30.06.17
30.06.17
€63.00
12.07.17
12.07.17
12.54%
12.07.17
12.07.17
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Deutsche Lufthansa AG
Start price
Target price
Perf. (%)
€19.65
29.06.17
29.06.17
€15.00
02.08.17
02.08.17
-2.81%
02.08.17
02.08.17
Known brand
Higher risks for its business
Significant cyclical dependencies
Canopy Growth Corp
Start price
Target price
Perf. (%)
€5.45
28.06.17
28.06.17
€29.90
05.04.18
05.04.18
219.22%
05.04.18
05.04.18
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Schaeffler AG
Start price
Target price
Perf. (%)
€12.89
28.06.17
28.06.17
€19.90
02.04.18
02.04.18
-2.72%
02.04.18
02.04.18
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Stada Arzneimittel AG VNA
Start price
Target price
Perf. (%)
€60.87
28.06.17
28.06.17
€70.00
18.08.17
18.08.17
17.13%
18.08.17
18.08.17
Uniqure B.V.
Start price
Target price
Perf. (%)
€5.41
27.06.17
27.06.17
€6.13
18.07.17
18.07.17
7.52%
18.07.17
18.07.17
Could be worthwhile Investment >10% per year
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€15.90
26.06.17
26.06.17
€19.46
02.08.17
02.08.17
-27.40%
02.08.17
02.08.17